Disc Medicine, Inc.
IRON
Rank in Stocks
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Share Price
$75.39
Last synced: 2026-10-22
Market Cap
$2.89B
Change (1 day)
-0.80%
Change (1 year)
-9.92%
Country
US
Trade Disc Medicine, Inc. (IRON)
Category
Healthcare
EPS for Disc Medicine, Inc. (IRON)
EPS as of June 2026 TTM: $-6.60
According to Disc Medicine, Inc. latest financial reports and stock price the company's current EPS (TTM) is $-6.60. At the end of 2024 the company had a EPS of $-3.96 an increase over its 2023 EPS that were of $-3.42.
EPS history for Disc Medicine, Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-6.60 | 9.82% |
| 2025 | $-6.01 | 51.77% |
| 2024 | $-3.96 | 15.79% |
| 2023 | $-3.42 | -92.41% |
| 2022 | $-45.05 | 0.38% |
| 2021 | $-44.88 | 66.10% |
| 2020 | $-27.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | -362.42% |
US
|
|
| $-7.98 | 20.91% |
US
|
|
| $-5.29 | -19.85% |
AU
|
|
| $12.97 | -296.53% |
BE
|
|
| $27.74 | -520.30% |
NL
|
